I agree 100%. Placing the strip in the mouth is easier for the patient to administer the meds over an inhaler. Cynaf has been significantly derisked after the recent results. Acorda bought the wrong company. Cynaf would be a strong acquisition for a bigger company given the results. I heard cynaf gave a presentation a few weeks ago to a packed house. A few days ago the stock took off on some big buys. Someone wanted in badly driving the price up. Stock is significantly undervalued at these levels.
News 
Market Data 
Discover 
